← Back to Clinical Trials
Recruiting NCT05786313

NCT05786313 Study of Individualized, Precise and Standardized Cervical Open-door Surgery for Cervical Spinal Stenosis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05786313
Status Recruiting
Phase
Sponsor Xijing Hospital
Condition Cervical Spinal Stenosis
Study Type INTERVENTIONAL
Enrollment 500 participants
Start Date 2023-03-01
Primary Completion 2025-12-31

Trial Parameters

Condition Cervical Spinal Stenosis
Sponsor Xijing Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age 28 Years
Max Age 85 Years
Start Date 2023-03-01
Completion 2025-12-31
Interventions
Centerpiece titanium plate

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

To evaluate the safety and effectiveness of individualized, precise and standardized open-door posterior cervical surgery through a single-center, exploratory clinical study, so as to provide a more reliable basis for the treatment of cervical spinal stenosis.

Eligibility Criteria

Inclusion Criteria: * The age of 28-85 years old; Through systematic clinical and imaging examination, patients diagnosed with C3-7 multilevel cervical spondylitis myelopathy or cervical spinal stenosis who need to undergo posterior cervical open-door surgery. * No contraindications in preoperative routine tests and examinations. * Informed consent of patients. Exclusion Criteria: * Cervical radiculopathy * Cervical kyphosis or instability * Cervical spondylosis caused by trauma, tumor, tuberculosis and metabolic diseases * Revision surgery or combined anterior-posterior surgery is required * Serious neurological diseases affect the postoperative effect evaluation * Mental illness cannot cooperate with follow-up * Contraindications for MRI examination * Patients themselves or their families do not agree to participate in the study * Other situations that are not suitable for study participation.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology